Abbott faces India scrutiny in cough syrup abuse investigation, documents show
AbbottAbbott(US:ABT) Reuters·2026-01-23 11:43

Core Viewpoint - Abbott Healthcare, an Indian drugmaker, is under investigation for the alleged misuse of its codeine-based cough syrup, which is known to be prone to abuse by addicts [1] Group 1: Company Overview - Abbott Healthcare's supply chain is currently being scrutinized as part of a broader investigation [1] Group 2: Industry Context - The investigation highlights concerns regarding the potential abuse of codeine-based medications within the pharmaceutical industry [1]